ReceptoPharm, Inc.
Plantation
About ReceptoPharm, Inc.
Receptopharm is a bio-pharmaceutical company developing proprietary therapeutic proteins for the treatment of several chronic, life-threatening viral, auto-immune and neuro-degenerative disorders, specifically including Rabies, HIV, and Myasthenia gravis (MG).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Website: receptopharm.com
- Phone: (954)356-1460
Canonical: https://fsome.com/organization/receptopharm-inc-2968740 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.